Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mish's Global Economic Trend Analysis -- Ignore unavailable to you. Want to Upgrade?

To: NOW who wrote (4166)	4/12/2004 2:18:19 PM
From: yard_man	Read Replies (1) \| Respond to of 116555

I disagree -- even on pharma ... You will have to admit, that we cannot test the alternative arrangement and that you cannot assess the efficacy of private vs publicly funded research ... Further, because of the way the system operates the price at which products are brought to market in pharma is almost irrelevant to the qtys purchased ... i.e. that a great deal of pharma research is publicly funded and we do have access to life saving therapies that result from such research -- does not imply that we got a good deal by funding it that way versus privately ...